Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A combination drug for treating pain, its preparation and preparation method

A drug, pharmacy technology, applied in the field of medicine

Active Publication Date: 2019-02-26
GUIZHOU YIBAI PHARMA CO LTD
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] At present, there are many drugs for treating pain, but due to problems such as adverse reactions and addiction, there are many defects and deficiencies in clinical application, and they have not been well developed. Good to meet the clinical needs; the present invention aims at the clinical pharmacological performance of cobotide and atropine, adopts a large number of tests to screen the prescription, and explores a fast onset, strong and long-lasting analgesic effect, avoiding or reducing addiction, Combination drugs and preparations with adverse reactions such as dependence

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A combination drug for treating pain, its preparation and preparation method
  • A combination drug for treating pain, its preparation and preparation method
  • A combination drug for treating pain, its preparation and preparation method

Examples

Experimental program
Comparison scheme
Effect test

experiment example

[0028] Experiment 1 Analgesic study of combined drugs

[0029] 1.1 Normal mouse hot plate experiment:

[0030] Put healthy mice (20±2g) with basically the same physical signs on a metal plate heated to 56±1°C, thermally stimulate the feet of the mice to produce pain and licking reactions. The latency of hind paw licking reaction in mice was used as the pain response index, which was the pain threshold. Mice with hind paw licking latency 30 s and jumping were excluded. Before administration, the pain threshold of each mouse was measured three times and the average value was taken as its basic pain threshold.

[0031] Administration method:

[0032] Experimental group 1-4: mice were given intraperitoneal injection of 0.5 μg atropine, tail vein injection of 0.15 μg naloxone, tail vein injection of 0.01 μg tropicamide (M4 muscarinic receptor antagonist), tail vein injection of 0.1 μg Methyllycaconitine (MLA, α7 nicotinic receptor antagonist) was administered in a volume of 0.1...

Embodiment 1

[0079] Example 1 Preparation of Injectable Microemulsion Containing Cobotide and Atropine (Injection Microemulsion A1)

[0080] Dissolve 40 mg of active ingredient cobotide and 20 mg of atropine in 300 ml of water for injection, add 6 g of poloxamer, and stir evenly to obtain an aqueous phase solution; heat 600 ml of soybean oil for injection at 100-110°C, add 5 g of poloxamer Magnesium monostearate, stir until the oil is clear and transparent, keep it warm at 105°C for 30 minutes, place it at room temperature to cool to obtain an oil phase solution; then pour the prepared water phase solution into the prepared oil phase solution, and make up the oil for injection to 1000ml, stir (2000 rpm) for 30 minutes, after homogenization, water-in-oil oil emulsion is obtained, which is divided into ampoules, sterilized, and injection microemulsion is obtained, each 2.5ml, containing the effective amount of cobotide 100μg, atropine 50μg.

Embodiment 2

[0081] Example 2 Preparation of Injectable Microemulsion Containing Cobotide and Atropine (Injection Microemulsion A2)

[0082]Dissolve 20 mg of kobotide and 8 mg of atropine in 280 ml of water for injection, add 2 g of Span-60, and stir well to obtain an aqueous phase solution; take 600 ml of soybean oil for injection and heat it at 100-110 ° C, add 2 g of Span-60 Magnesium monostearate, stir until the oil is clear and transparent, keep it warm at 105°C for 30 minutes, place it at room temperature to cool to obtain an oil phase solution; then pour the prepared water phase solution into the prepared oil phase solution, and make up the oil for injection to 1000ml, stir (2000 rpm) for 30 minutes, after homogenization, water-in-oil oil emulsion is obtained, which is divided into ampoules, sterilized, and injection microemulsion is obtained, each 2.5ml, containing the effective amount of cobotide 50μg, atropine 20μg.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a combined drug for treating pain, its preparation and preparation method. The combined drug is made of active ingredients cobotide, atropine and pharmaceutical excipients. Very ideal; the present invention also discloses a slow-release injection microemulsion for treating pain. The slow-release injection microemulsion uses oil for injection as a solvent, and the medicinal active ingredients are evenly dispersed in the oily vehicle by emulsification Among them, a water-in-oil emulsion is formed, so that the preparation can achieve the purpose of slow and stable drug release, the pain treatment effect is more significant, and the toxic and side effects of the drug are avoided, and the preparation process of the compound injection microemulsion is simple, and the cost is low. Suitable for large-scale industrial production.

Description

Technical field: [0001] The invention belongs to the technical field of medicines, and relates to a combined drug for treating pain, in particular to a combined drug made of medicinal active ingredients cobotide and atropine and a preparation thereof. Background technique: [0002] Pain is an unpleasant feeling and emotional experience that occurs when the body is damaged. It is a clinical manifestation of a group of complex pathological and physiological changes. Pain can be local or a reflection of systemic diseases. The above diseases with "pain" as the main symptom are collectively referred to as "pain". At present, opioid analgesics and non-steroidal anti-inflammatory drugs are classic clinical analgesics, and have a long history of being used in pain treatment. However, there are also many defects and deficiencies in its clinical application, and the adverse reactions are also daunting. For example, some strong opioid analgesics that are clinically used for severe pa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/17A61K9/107A61P29/00A61P35/00A61P25/02A61P25/00A61K31/46
Inventor 窦啟玲苏凯
Owner GUIZHOU YIBAI PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com